KORU Medical Systems Inc. is a medical technology company. It focused on development, manufacturing and commercialization of patient-centric large volume subcutaneous infusion solutions. KORU Medical Systems Inc., formerly known as REPRO MEDSYSTEM, is based in MAHWAH, N.J.
| Revenue (Most Recent Fiscal Year) | $33.65M |
| Net Income (Most Recent Fiscal Year) | $-6.07M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 6.73 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 15.95 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -9.45% |
| Net Margin (Trailing 12 Months) | -9.49% |
| Return on Equity (Trailing 12 Months) | -22.43% |
| Return on Assets (Trailing 12 Months) | -13.86% |
| Current Ratio (Most Recent Fiscal Quarter) | 2.48 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.92 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.01 |
| Inventory Turnover (Trailing 12 Months) | 4.08 |
| Book Value per Share (Most Recent Fiscal Quarter) | $0.37 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.02 |
| Earnings per Share (Most Recent Fiscal Year) | $-0.13 |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.08 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Common Shares Outstanding | 46.32M |
| Free Float | 36.78M |
| Market Capitalization | $263.11M |
| Average Volume (Last 20 Days) | 0.21M |
| Beta (Past 60 Months) | 0.58 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 20.60% |
| Percentage Held By Institutions (Latest 13F Reports) | 58.60% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |